Teresa-Anne Colella, Ph.D.

Affiliations: 
2001 University of Virginia, Charlottesville, VA 
Area:
Immunology
Google:
"Teresa-Anne Colella"

Parents

Sign in to add mentor
Victor H. Engelhard grad student 2001 UVA
 (Self -tolerance to the murine homologue of a tyrosinase-derived melanoma antigen.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nichols LA, Chen Y, Colella TA, et al. (2007) Deletional self-tolerance to a melanocyte/melanoma antigen derived from tyrosinase is mediated by a radio-resistant cell in peripheral and mesenteric lymph nodes. Journal of Immunology (Baltimore, Md. : 1950). 179: 993-1003
Engelhard VH, Bullock TN, Colella TA, et al. (2002) Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy. Immunological Reviews. 188: 136-46
Bullock TN, Mullins DW, Colella TA, et al. (2001) Manipulation of avidity to improve effectiveness of adoptively transferred CD8(+) T cells for melanoma immunotherapy in human MHC class I-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 5824-31
Mullins DW, Bullock TN, Colella TA, et al. (2001) Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 167: 4853-60
Engelhard VH, Bullock TN, Colella TA, et al. (2000) Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. Cancer Journal (Sudbury, Mass.). 6: S272-80
Slingluff CL, Colella TA, Thompson L, et al. (2000) Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunology, Immunotherapy : Cii. 48: 661-72
Colella TA, Bullock TN, Russell LB, et al. (2000) Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. The Journal of Experimental Medicine. 191: 1221-32
Bullock TN, Colella TA, Engelhard VH. (2000) The density of peptides displayed by dendritic cells affects immune responses to human tyrosinase and gp100 in HLA-A2 transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 164: 2354-61
Luckey CJ, King GM, Marto JA, et al. (1998) Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. Journal of Immunology (Baltimore, Md. : 1950). 161: 112-21
Kittlesen DJ, Thompson LW, Gulden PH, et al. (1998) Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implications for tumor vaccine development. Journal of Immunology (Baltimore, Md. : 1950). 160: 2099-106
See more...